Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 2/20 | 0.68 |
| ▸ | IGF1R | P08069 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.54 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24197389 | 0.94 | MAOB (0.61) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL1171813 | 0.94 | CALM1 (0.66) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL8413383 | 0.92 | CALM1 (0.63) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL8862032 | 0.92 | CALM1 (0.63) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL4740749 | 0.92 | CALM1 (0.63) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| Nitric Acid SCHEMBL9874342 | 0.88 | CALM1 (0.54) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL77472 | 0.86 | TAAR1 (0.61) | CALM1IGF1RALOX15TAAR1CYP4A11 | |
| SCHEMBL244070 | 0.86 | CALM1 (0.79) | CALM1IGF1RALOX15TAAR1ALOX5 | |
| SCHEMBL4254058 | 0.86 | CALM1 (0.72) | CALM1IGF1RALOX15TAAR1ALOX5 | |
| SCHEMBL31497794 | 0.84 | TAAR1 (0.59) | CALM1IGF1RALOX15TAAR1CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115385782-A | Mechanochemical synthesis method of benzoyl compound | 兰州大学 | 2022-11-25 | — | — | CN | claimed |
| CN-108440257-B | Production process for preparing anethole by catalyzing dehydration of p-methoxyphenylpropanol | 宿迁科思化学有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-103058835-A | Synthetic method of anethole | HUAIAN WANBANG AROMATIC CHEMICALS INDUSTRY CO LTD | 2013-04-24 | — | — | CN | claimed |
| EP-2374853-A1 | Cyanate ester-based pressure sensitive adhesive | CORNERSTONE RESEARCH GROUP, INC. (US) | 2011-10-12 | — | — | EP | claimed |
| US-20100137554-A1 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. | 2010-06-03 | — | — | US | claimed |
| EP-1979397-A4 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RES GROUP INC (US) | 2009-04-08 | — | — | EP | claimed |
| EP-1979397-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-10-15 | — | — | EP | claimed |
| WO-2008051241-A2 | SHAPE MEMORY CYANATE ESTER COPOLYMERS | CORNERSTONE RESEARCH GROUP, INC. (US) | 2008-05-02 | — | — | WO | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6613317-B1 | In particular northern corn rootworm | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2003-09-02 | — | — | US | claimed |
| US-20010056085-A1 | Methods of using vesicant drug formulations | RAMU AVNER (US) | 2001-12-27 | — | — | US | claimed |
| US-20250223291-A1 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS | INCYTE CORPORATION | 2025-07-10 | — | — | US | disclosed |
| CN-115703776-B | Plasmin inhibitor, preparation method and application thereof | 赛诺哈勃药业（成都）有限公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-4561585-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| EP-4562019-A1 | IP5 SUBSTITUTED COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| US-4289787-A | PROLONG ACTION POTENTIAL OF CARDIAC TISSUE | ELI LILLY AND COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| EP-0002604-A1 | Quaternary ammonium salts, and their formulations and preparation | ELI LILLY AND COMPANY (US) | 1979-06-27 | — | — | EP | disclosed |
| US-4012389-A | ANTICOAGULANTS | DONAU-PHARMAZIE GESELLSCHAFT M.B.H. (OE) | 1977-03-15 | — | — | US | disclosed |
| US-3959190-A | ALKYL SULFIDE- CROSSLINKED POLYSTYRENE | DYNAPOL (US) | 1976-05-25 | — | — | US | disclosed |
| US-3935214-A | ANTICOAGULANT | DONAU-PHARMAZIE GESELLSCHAFT M.B.H. (OE) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250223291-A1 | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS | ERBB2, MERTK, ABL1 | CALM1 460/4885IGF1R 77/4885ALOX15 4679/4885 |
| US-20010056085-A1 | Methods of using vesicant drug formulations | UGT1A1, SLC47A1, UGT1A10 | CALM1 2848/4885IGF1R 3795/4885ALOX15 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.